These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19034426)

  • 1. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU.
    Meyer E; Lapatschek M; Bechtold A; Schwarzkopf G; Gastmeier P; Schwab F
    Intensive Care Med; 2009 May; 35(5):862-70. PubMed ID: 19034426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1495-1502. PubMed ID: 32221726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
    Marquet A; Vibet MA; Caillon J; Javaudin F; Chapelet G; Montassier E; Batard E
    Microb Drug Resist; 2018 Sep; 24(7):987-994. PubMed ID: 29489447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting.
    Nadrah K; Pirs M; Kreft S; Mueller Premru M; Beovic B
    J Chemother; 2018 May; 30(3):150-156. PubMed ID: 29431031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
    Kim JY; Sohn JW; Park DW; Yoon YK; Kim YM; Kim MJ
    J Antimicrob Chemother; 2008 Aug; 62(2):416-21. PubMed ID: 18413317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
    van der Steen M; Leenstra T; Kluytmans JA; van der Bij AK;
    PLoS One; 2015; 10(9):e0138088. PubMed ID: 26381746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance.
    Abdelraouf K; Chavda KD; Satlin MJ; Jenkins SG; Kreiswirth BN; Nicolau DP
    Int J Antimicrob Agents; 2020 Mar; 55(3):105885. PubMed ID: 31923568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
    Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
    Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.
    Lan CK; Hsueh PR; Wong WW; Fung CP; Lau YT; Yeung JY; Young GT; Su CC
    J Microbiol Immunol Infect; 2003 Sep; 36(3):182-6. PubMed ID: 14582562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates.
    Lee J; Oh CE; Choi EH; Lee HJ
    Int J Infect Dis; 2013 Aug; 17(8):e638-43. PubMed ID: 23523562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.
    French GL; Shannon KP; Simmons N
    J Clin Microbiol; 1996 Feb; 34(2):358-63. PubMed ID: 8789016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
    Huang Y; Zhuang S; Du M
    Infection; 2007 Oct; 35(5):339-45. PubMed ID: 17721736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by
    Zhen X; Stålsby Lundborg C; Sun X; Hu X; Dong H
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Arya SC; Agarwal N; Solanki BS; Agarwal S
    Singapore Med J; 2007 Jun; 48(6):600-1. PubMed ID: 17538771
    [No Abstract]   [Full Text] [Related]  

  • 17. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.
    Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P
    Crit Care; 2010; 14(3):R113. PubMed ID: 20546564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
    Han SB; Jung SW; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK; Park YJ
    Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
    JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.